ArticleAmerican journal of translational research2025

Mesenchymal stem cells promote erlotinib resistance in non-small cell lung cancer through the HGF-AKT/ERK1/2-OPN pathway.

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.